Gerry Oster

15.9k total citations · 3 hit papers
237 papers, 12.2k citations indexed

About

Gerry Oster is a scholar working on Economics and Econometrics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerry Oster has authored 237 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Economics and Econometrics, 44 papers in Surgery and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerry Oster's work include Health Systems, Economic Evaluations, Quality of Life (39 papers), Bone health and treatments (16 papers) and Pain Mechanisms and Treatments (15 papers). Gerry Oster is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (39 papers), Bone health and treatments (16 papers) and Pain Mechanisms and Treatments (15 papers). Gerry Oster collaborates with scholars based in United States, Switzerland and United Kingdom. Gerry Oster's co-authors include John Edelsberg, Derek Weycker, Montserrat Vera‐Llonch, Ariel Berger, Graham A. Colditz, Ellen Dukes, David R. Thompson, Williamson Z. Bradford, Daniel A. Ollendorf and Ganesh Raghu and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Gerry Oster

233 papers receiving 11.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and Prevalence of Idiopathic Pulmonary Fibrosis

2006 965 citations Derek Weycker, John Edelsberg et al. profile →
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

2002 959 citations Gerry Oster, Montserrat Vera‐Llonch et al. CHEST Journal profile →
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation

2001 516 citations Gerry Oster, John Edelsberg et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Gerry Oster	3.2k	2.0k	1.9k	1.9k	1.5k	237	12.2k
Matthias Briel	3.7k 1.2×	3.1k 1.6×	1.0k 0.5×	2.9k 1.6×	2.0k 1.4×	215	14.0k
Chris R. Cardwell	2.8k 0.9×	1.1k 0.6×	2.1k 1.1×	2.3k 1.2×	1.1k 0.8×	307	12.7k
Roman Jaeschke	2.6k 0.8×	2.9k 1.5×	906 0.5×	4.4k 2.4×	1.5k 1.0×	68	17.7k
Reem A. Mustafa	1.9k 0.6×	2.0k 1.0×	1.2k 0.7×	2.6k 1.4×	1.0k 0.7×	226	15.7k
Brian L. Strom	1.3k 0.4×	2.6k 1.3×	1.1k 0.6×	2.9k 1.5×	1.2k 0.8×	293	15.1k
D. John M. Reynolds	2.4k 0.7×	1.5k 0.8×	1.4k 0.7×	4.3k 2.3×	1.6k 1.1×	13	15.7k
Andrew R. Willan	3.0k 0.9×	1.8k 0.9×	1.6k 0.8×	2.3k 1.2×	1.6k 1.1×	264	17.4k
Adrían V. Hernández	3.3k 1.0×	2.1k 1.1×	1.1k 0.6×	2.5k 1.3×	1.1k 0.8×	320	13.3k
Yong‐Fang Kuo	3.3k 1.0×	2.7k 1.4×	3.2k 1.7×	2.2k 1.2×	932 0.6×	497	14.0k
Mark Helfand	1.4k 0.4×	2.0k 1.0×	875 0.5×	2.8k 1.5×	1.1k 0.7×	103	15.2k

Countries citing papers authored by Gerry Oster

Since Specialization

Citations

This map shows the geographic impact of Gerry Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerry Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerry Oster more than expected).

Fields of papers citing papers by Gerry Oster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerry Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerry Oster. The network helps show where Gerry Oster may publish in the future.

Co-authorship network of co-authors of Gerry Oster

This figure shows the co-authorship network connecting the top 25 collaborators of Gerry Oster. A scholar is included among the top collaborators of Gerry Oster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerry Oster. Gerry Oster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hagiwara, May, et al.. (2015). Change in Healthcare Utilization and costs in Patients with Major Depressive Disorder (MDD) initiating adjunctive Therapy with Second-Generation Antipsychotics (SGAS). Value in Health. 18(3). A119–A119. 1 indexed citations

Berger, Ariel, John Edelsberg, Holly Yu, & Gerry Oster. (2014). Clinical and Economic Consequences of Post-Operative Infections following Major Elective Surgery in U.S. Hospitals. Surgical Infections. 15(3). 322–327. 9 indexed citations

Berger, Ariel, Gerry Oster, John Edelsberg, Xingyue Huang, & David J. Weber. (2013). Initial Treatment Failure in Patients with Complicated Skin and Skin Structure Infections. Surgical Infections. 14(3). 304–312. 30 indexed citations

Berger, Ariel, et al.. (2012). SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons: A Cautionary Tale Concerning Antibiotic Therapy for Infectious Disease. Value in Health. 15(4). A4–A5. 1 indexed citations

Berger, Ariel, John Edelsberg, Michael Treglia, José Alvir, & Gerry Oster. (2011). PMH22 CLINICAL AND ECONOMIC CONSEQUENCES OF LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH GENERALIZED ANXIETY DISORDER. Value in Health. 14(3). A189–A189. 1 indexed citations

Oster, Gerry, et al.. (2011). PSS28 Economic Burden of Advanced Melanoma: Findings From A Large US Health Insurance Database. Value in Health. 14(7). A507–A507. 3 indexed citations

Berger, Ariel, John Edelsberg, Gary Inglese, Samir Bhattacharyya, & Gerry Oster. (2009). Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.. PubMed. 15(8). 509–18. 99 indexed citations

Sadosky, Alesia, Ariel Berger, Gergana Zlateva, & Gerry Oster. (2009). Identification of fibromyalgia patients who may not be appropriate candidates for duloxetine or pregabalin therapy. Journal of Pain. 10(4). S43–S43. 1 indexed citations

Edelsberg, John, Ariel Berger, Scott R. Schell, et al.. (2008). Economic Consequences of Failure of Initial Antibiotic Therapy in Hospitalized Adults with Complicated Intra-Abdominal Infections. Surgical Infections. 9(3). 335–347. 49 indexed citations

10.

Berger, Ariel, Ellen Dukes, Susan Martin, John Edelsberg, & Gerry Oster. (2007). Characteristics and healthcare costs of patients with fibromyalgia syndrome. International Journal of Clinical Practice. 61(9). 1498–1508. 256 indexed citations

11.

Delea, Thomas E., James M. McKiernan, J. Brandman, et al.. (2006). Impact of Skeletal Complications on Total Medical Care Costs among Patients with Bone Metastases of Lung Cancer. Journal of Thoracic Oncology. 1(6). 571–576. 50 indexed citations

12.

Weycker, Derek, John Edelsberg, Gerry Oster, & Gregory Tino. (2005). ASSOCIATION BETWEEN RISK OF ACUTE EXACERBATIONS AND AGE IN PATIENTS WITH BRONCHIECTASIS. CHEST Journal. 128(4). 153S–153S. 1 indexed citations

13.

Berger, Ariel, Karen Chung, David Gelmont, & Gerry Oster. (2004). Clinical Outcomes in Patients With Alpha1-Antitrypsin Deficiency And Emphysema Receiving Alpha1-Proteinase Inhibitor Augmentation Therapy. CHEST Journal. 126(4). 708S–708S. 1 indexed citations

14.

Delea, Thomas E., Richard H. Stanford, May Hagiwara, John Edelsberg, & Gerry Oster. (2004). 821-5 Risks of death and hospitalization in heart failure patients receiving carvedilol versus metoprolol tartrate: A retrospective claims-based study. Journal of the American College of Cardiology. 43(5). A196–A196. 1 indexed citations

15.

Delea, Thomas E., May Hagiwara, John Edelsberg, & Gerry Oster. (2002). Exposure to glitazone antidiabetics and risk of heart failure among persons with type 2 diabetes: a retrospective population-based cohort analysis. Journal of the American College of Cardiology. 39. 184–184. 12 indexed citations

16.

Cheville, Andrea, et al.. (2001). A Randomized Trial of Controlled-Release Oxycodone During Inpatient Rehabilitation Following Unilateral Total Knee Arthroplasty. Journal of Bone and Joint Surgery. 83(4). 572–576. 78 indexed citations

17.

Fowler, Michael B., Montserrat Vera‐Llonch, Gerry Oster, et al.. (2001). Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. Journal of the American College of Cardiology. 37(6). 1692–1699. 53 indexed citations

18.

Thompson, David R., et al.. (1996). Patterns of Antidepressant Use and Their Relation to Costs of Care. The American Journal of Managed Care. 2. 75 indexed citations

19.

Richter, James M., Graham A. Colditz, Daniel M. Huse, Thomas E. Delea, & Gerry Oster. (1989). Cimetidine and adverse reactions: A meta-analysis of randomized clinical trials of short-term therapy☆. The American Journal of Medicine. 87. 278–284. 4 indexed citations

20.

Oster, Gerry, et al.. (1987). Accident- and injury-related health-care utilization among benzodiazepine users and nonusers.. PubMed. 48 Suppl. 17–21. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact